Leif W. Ellisen

Oncology
55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2026

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

Journal: Journal for immunotherapy of cancer
Published: March 25, 2026

Sensitive detection of somatic mutations in GC-rich cancer gene promoters.

Sensitive detection of somatic mutations in GC-rich cancer gene promoters.

Journal: NAR cancer
Published: November 05, 2025

Breast cancer inequities: the intersectional role of social epidemiology and tumor biology.

Breast cancer inequities: the intersectional role of social epidemiology and tumor biology.

Journal: Cancer causes & control : CCC
Published: October 17, 2025

Current landscape of sequencing ADCs in metastatic breast cancer.

Current landscape of sequencing ADCs in metastatic breast cancer.

Journal: Therapeutic advances in medical oncology
Published: July 17, 2025

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

Journal: The Lancet. Oncology
Published: May 07, 2025

Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates.

Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates.

Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025

Correction: CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance.

Correction: CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance.

Journal: Oncogene
Published: April 02, 2025

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Journal: Breast cancer research and treatment
Published: February 06, 2025

Exploring the "chemo" in chemoimmunotherapy for triple-negative breast cancer.

Exploring the "chemo" in chemoimmunotherapy for triple-negative breast cancer.

Journal: Cancer cell
Published: January 25, 2025

Selection biases in the systematic collection of breast biobank specimens.

Selection biases in the systematic collection of breast biobank specimens.

Journal: NPJ breast cancer
Published: January 04, 2025

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer.

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer.

Journal: bioRxiv : the preprint server for biology
Published: December 16, 2024
Showing 1-12 of 106

Last Updated: 09/26/2026